1. 338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer. Issue 9 (September 2016) Authors: Rho, Y.S.; Gilabert, M.; Polom, K.; Aladashvili, A.; Kubackova, K.; Megdanova, V.; Coleman, N.; Greally, M.; Marrelli, D.; Roviello, F.; McDermott, R.; Petrova, V.; Mihaylova, Z.; Zbynek, B.; Peausova, J.; Batist, G.; Azoulay, L.; Kavan, P. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative net cost impact of the utilization of panitumumab versus cetuximab for the treatment of patients with metastatic colorectal cancer in Canada. (1st February 2016) Authors: Pettigrew, M.; Kavan, P.; Surprenant, L.; Lim, H. J. Journal: Journal of medical economics Issue: Volume 19:Number 2(2016) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗